‘Living medicine’ created to tackle drug-resistant lung infections
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria whic1
We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria whic1
Researchers from Hospital Clínic-IDIBAPS are leading a study that provides new evidence regarding the benefits and risks of corticosteroid treatment,1
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
Vaccination against flu and pneumonia is an important preventive measure that helps to stop these acute infections from developing, and thus helps to1
Interview with Dr Catia Cilloniz, a microbiologist and doctor of medicine at the applied research group on respiratory infections and critical illnes1
IDIBAPS-FCRB looks for talented professionals to meet the needs that appear periodically.
Enter